title: The value of quantitative patient preferences in regulatory benefit-risk assessment.
abstract: Quantitative patient preferences are a method to involve patients in regulatory benefit-risk assessment. Assuming preferences can be elicited, there might be multiple advantages to their use. Legal, methodological and procedural issues do however imply that preferences are currently at most part of the solution on how to best involve patients in regulatory decision making. Progress is recently made on these issues.
authors.affiliation: Department Health Technology and Services Research, School of Management and Governance, University of Twente, Enschede, The Netherlands.
authors.forename: Mart Oude
authors.initials: MO
authors.lastname: Egbrink
authors.affiliation: Department Health Technology and Services Research, School of Management and Governance, University of Twente, Enschede, The Netherlands.
authors.forename: Maarten
authors.initials: M
authors.lastname: IJzerman
keywords: European Medicines Agency; benefit-risk assessment; patient involvement; preferences